Speaker
Director, Neuromuscular Research, Dyne Therapeutics
Susana Correia, Director, Neuromuscular Research at Dyne Therapeutics, is speaking at 8th CNS Drug Delivery Summit (Boston, United States of America, 1–3 Dec 2026) in the session “Enabling Targeted Oligonucleotide Delivery to CNS for the Treatment of Neurological Pathologies”.
1–3 Dec 2026Boston, United States of America
President & Chief Executive Officer, ArmaGen & JCR Pharmaceuticals
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Head of Device Clinical, Biogen
Executive Director, Drug Delivery & Devices DDCS, Eli Lilly
Head of IDU Device Development & Manufacturing, Biogen
Principal Engineer, Delivery, Device, and Connected Solutions (DDCS), Eli Lilly
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Susana Correia, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].